Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Apply
Nivolumab & Relatlimab vs. Pembrolizumab
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step